Cannabis use is associated with schizotypy and attentional disinhibition

被引:121
作者
Skosnik, PD
Spatz-Glenn, L
Park, S [1 ]
机构
[1] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA
[2] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA
关键词
anandamide; attention; cannabis; inhibition; schizophrenia; schizotypy;
D O I
10.1016/S0920-9964(00)00132-8
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
While most neurochemical research into the pathogenesis of schizophrenia (SZ) has focused on the dopaminergic, glutamatergic, and serotonergic systems, the exact nature and cause of this disorder have proven intractable. Given the recent discovery and elucidation of the endogenous cannabinioid system, a re-examination of the cannabis-induced exacerbation hypothesis of SZ is warranted. The purpose of the present study was to assess whether current cannabis users exhibit personality correlates and neurocognitive deficits similar to those observed in SZ patients. 15 current cannabis users, 15 drug-free controls, and IO past cannabis users were assessed on tasks which assess attentional inhibition, spatial working memory, olfactory identification, and schizotypal personality. Current cannabis users demonstrated deficits in attentional inhibition, decreased reaction time, and significantly higher scores on the schizotypal personality questionnaire (SPQ) compared with the non-using and past cannabis using groups. No group differences were found on the working memory or olfactory identification tasks. These results suggest that cannabis use can mimic attentional deficits seen in acute schizophrenia and is associated with schizotypal personality, thus setting the stage for a possible cannabinoid model of SZ. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:83 / 92
页数:10
相关论文
共 52 条
[1]  
ABOOD ME, 1992, TRENDS PHARMACOL SCI, V13, P202
[2]  
ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P943
[3]   CANNABIS AND SCHIZOPHRENIA - A LONGITUDINAL-STUDY OF SWEDISH CONSCRIPTS [J].
ANDREASSON, S ;
ENGSTROM, A ;
ALLEBECK, P ;
RYDBERG, U .
LANCET, 1987, 2 (8574) :1483-1486
[4]  
[Anonymous], PSYCHOPATHOLOGY BRAI
[5]   PSYCHIATRIC ASSESSMENT OF 30 CHRONIC USERS OF CANNABIS AND 30 MATCHED CONTROLS [J].
BEAUBRUN, MH ;
KNIGHT, F .
AMERICAN JOURNAL OF PSYCHIATRY, 1973, 130 (03) :309-311
[6]   CANNABIS - PSYCHOLOGICAL EFFECTS OF CHRONIC HEAVY USE - CONTROLLED STUDY OF INTELLECTUAL FUNCTIONING IN CHRONIC USERS OF HIGH POTENCY CANNABIS [J].
BOWMAN, M ;
PIHL, RO .
PSYCHOPHARMACOLOGIA, 1973, 29 (02) :159-170
[7]   HALLUCINOGENIC DRUGS AS PRECIPITANTS OF SCHIZOPHRENIA [J].
BREAKEY, WR ;
GOODELL, H ;
LORENZ, PC ;
MCHUGH, PR .
PSYCHOLOGICAL MEDICINE, 1974, 4 (03) :255-261
[8]   Spatial working memory deficits and their relationship to negative symptoms in unmedicated schizophrenia patients [J].
Carter, C ;
Robertson, L ;
Nordahl, T ;
Chaderjian, M ;
Kraft, L ;
OShoraCelaya, L .
BIOLOGICAL PSYCHIATRY, 1996, 40 (09) :930-932
[9]  
CHEN J, 1989, Society for Neuroscience Abstracts, V15, P1096
[10]   DELTA-9-TETRAHYDROCANNABINOL PRODUCES NALOXONE-BLOCKABLE ENHANCEMENT OF PRESYNAPTIC BASAL DOPAMINE EFFLUX IN NUCLEUS-ACCUMBENS OF CONSCIOUS, FREELY-MOVING RATS AS MEASURED BY INTRACEREBRAL MICRODIALYSIS [J].
CHEN, JP ;
PAREDES, W ;
LI, J ;
SMITH, D ;
LOWINSON, J ;
GARDNER, EL .
PSYCHOPHARMACOLOGY, 1990, 102 (02) :156-162